http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01309687-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f62824da9d41b863ecaed02e6fd87d2 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-96 |
filingDate | 1988-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16df05b603c384132d9adf3308dc523f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5884f9581c85fccaf0d8020fcb9205d9 |
publicationDate | 1989-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H01309687-A |
titleOfInvention | Stabilized n-acetyl-beta-d-glucosaminidase and controlling drug preparation containing the same enzyme |
abstract | PURPOSE: To obtain the subject preparation having excellent preservability, capable of keeping the enzymatic activity over a long period and suitable as a contrast for clinic examination by dissolving acetyl-glucosaminidase in a solution of an ammonium salt, crosslinking with a dialdehyde compound and separating the product. n CONSTITUTION: The objective drug preparation can be prepared by dissolving (A) N-acetyl-β-D-glucosaminidase in (B) a solution of an ammonium salt such as ammonium sulfate having a concentration of preferably 2-3.5 M, reacting the enzyme with (C) a dialdehyde compound such as glutaraldehyde added to the solution, removing excess components B and C by dialysis, ultrafiltration, etc., and freeze-drying the product. n COPYRIGHT: (C)1989,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006271257-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008245559-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4741270-B2 |
priorityDate | 1988-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.